You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 8, April 28, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (48)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Women's Health
 •Women's Health, Other
 •Aging/ Geriatrics
 •Adverse Effects
 •Alert me on articles by topic

Central Nervous System Active Medications and Risk for Fractures in Older Women

Kristine E. Ensrud, MD, MPH; Terri Blackwell, MA; Carol M. Mangione, MD, MSPH; Paula J. Bowman, MPH; Douglas C. Bauer, MD; Ann Schwartz, PhD; Joseph T. Hanlon, PharmD; Michael C. Nevitt, PhD; Mary A. Whooley, MD; for the Study of Osteoporotic Fractures Research Group

Arch Intern Med. 2003;163:949-957.

Background  Use of central nervous system (CNS) active medications may increase the risk for fractures. Prior studies are limited by incomplete control of confounders.

Methods  To determine whether use of CNS active medications, including benzodiazepines, antidepressants, anticonvulsants, and narcotics, increases fracture risk in elderly, community-dwelling women, we examined use of these 4 categories of medications in a cohort of 8127 older women and followed the participants prospectively for incident nonspine fractures, including hip fractures. Current use of CNS active medications was assessed by interview with verification of use from containers between 1992 and 1994 and between 1995 and 1996. Use was coded as a time-dependent variable. Incident nonspine fractures occurring after the initial medication assessment until May 31, 1999, were confirmed by radiographic reports.

Results  During an average follow-up of 4.8 years, 1256 women (15%) experienced at least one nonspine fracture, including 288 (4%) with first hip fractures. Compared with nonusers, women taking narcotics (multivariate hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06-1.83) and those taking antidepressants (multivariate HR, 1.25; 95% CI, 0.99-1.58) had increases in the risks for any nonspine fractures. Women taking tricyclic antidepressants and those using selective serotonin reuptake inhibitors (SSRIs) had similar fracture rates. There were no independent associations between benzodiazepine use or anticonvulsant use and risk for nonspine fracture. Women taking antidepressants compared with nonusers had a 1.7-fold increase in the risk for hip fracture (multivariate HR, 1.65; 95% CI, 1.05-2.57). We did not observe independent associations between use of any of the other 3 classes of CNS active medications and risk of hip fracture.

Conclusions  Community-dwelling older women taking narcotics have an increased risk for any nonspine fracture, and those taking antidepressants have a greater risk for nonspine fractures, including hip fracture. Rates of fracture were similar in women taking tricyclic antidepressants and those using SSRIs. Benzodiazepine use and anticonvulsant use were not independently associated with an increased risk of nonspine fractures, including hip fracture.


From the Department of Medicine and Center for Chronic Disease Outcomes Research, VA Medical Center (Dr Ensrud), and Division of Epidemiology, School of Public Health (Dr Ensrud and Ms Bowman), and College of Pharmacy (Dr Hanlon), University of Minnesota, Minneapolis; and Department of Epidemiology and Biostatistics, University of California, San Francisco (Ms Blackwell and Drs Bauer, Schwartz, Nevitt, and Whooley); Department of Medicine, University of California, Los Angeles (Dr Mangione); and Department of Medicine, VA Medical Center, San Francisco (Dr Whooley). No proprietary interest had a role in the collection, analysis, or interpretation of the data or in the decision to submit the paper for publication.


RELATED LETTERS

Opioid Osteoporosis
Harry W. Daniell
Arch Intern Med. 2004;164(3):338.
EXTRACT | FULL TEXT  

Opioid Osteoporosis—Reply
Kristine E. Ensrud
Arch Intern Med. 2004;164(3):338.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive outcome following kidney transplantation
Gelb et al.
Nephrol Dial Transplant 2008;23:1032-1038.
ABSTRACT | FULL TEXT  

Concerns About Bone Safety of Tricyclic Antidepressant Therapy
Lim and Chan
Arch Intern Med 2008;168:435-436.
FULL TEXT  

Medication as a Risk Factor for Falls: Critical Systematic Review
Hartikainen et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:1172-1181.
ABSTRACT | FULL TEXT  

Use of Antidepressants and Rates of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures
Diem et al.
Arch Intern Med 2007;167:1240-1245.
ABSTRACT | FULL TEXT  

Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Haney et al.
Arch Intern Med 2007;167:1246-1251.
ABSTRACT | FULL TEXT  

Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
Richards et al.
Arch Intern Med 2007;167:188-194.
ABSTRACT | FULL TEXT  

Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates
Wagner et al.
ANN INTERN MED 2007;146:96-103.
ABSTRACT | FULL TEXT  

The use of benzodiazepines in palliative care
Henderson et al.
Palliat Med 2006;20:407-412.
ABSTRACT  

Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding
Normand et al.
BMJ 2005;330:1021-1023.
FULL TEXT  

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
Mamdani et al.
BMJ 2005;330:960-962.
FULL TEXT  

Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth
Warden et al.
Endocrinology 2005;146:685-693.
ABSTRACT | FULL TEXT  

Treatment of chronic pain in persons with dementia: An overview
Rubey
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:12-20.
ABSTRACT  

Use of {beta}-Blockers and Risk of Fractures
Schlienger et al.
JAMA 2004;292:1326-1332.
ABSTRACT | FULL TEXT  

Antiepileptic drug use increases rates of bone loss in older women: A prospective study
Ensrud et al.
Neurology 2004;62:2051-2057.
ABSTRACT | FULL TEXT  

Benzodiazepine Use Among Depressed Patients Treated in Mental Health Settings
Valenstein et al.
Am. J. Psychiatry 2004;161:654-661.
ABSTRACT | FULL TEXT  

Opioid Osteoporosis
Daniell
Arch Intern Med 2004;164:338-338.
FULL TEXT  

Link Between Psychiatric Drugs, Fractures More Complex Than Thought
Rosack
Psychiatr. News 2003;38:21-21.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.